CORRELATION OF PLASMA INTERLEUKIN 1 LEVELS WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
References (31)
- et al.
Specific interleukin 1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis
Lancet
(1987) Interleukin 1
Rev Infect Dis
(1984)Immune diseases: many roles for interleukin 1
Nature
(1985)- et al.
Cloning, sequence and expression of 2 distinct human IL-1 cDNAs
Nature
(1985) - et al.
Molecular biology of interleukin 1
Cold Spring Harbor Symp Quant Biol
(1986) Interleukin 1: amino acid sequences, multiple biological activities and comparison with tumour necrosis factor
- et al.
Identification of a common class of high affinity receptors for both types of porcine mterleukin 1 on connective tissue cells
Nature
(1986) - et al.
Soluble mediators of immunity: interleukins
- et al.
An interleukin 1-like factor stimulates bone resorption in vitro
Nature
(1983) - et al.
A cartilage catabolic factor from synovium
Biochem J
(1979)
Interleukin 1 and the pathogenesis of acute phase response
N Engl J Med
(1984)
The pyrogenic and mitogenic actions of interleukin 1 are related
Nature
(1983)
Interleukin 1: an immunological perspective
Annu Rev Immunol
(1985)
Interleukin 1 activity m synovial fluid of patients with rheumatoid arthritis
Arthritis Rheum
(1982)
Cited by (463)
Rheumatoid Arthritis, Osteoarthritis, and Gout
2022, Comprehensive PharmacologyRheumatoid arthritis: Immunogenetic factors and immune therapies
2022, Immunogenetics: a Molecular and Clinical Overview: Clinical Applications of Immunogenetics, Volume IIParadoxical role of Breg-inducing cytokines in autoimmune diseases
2019, Journal of Translational AutoimmunityProposing novel TNFα direct inhibitor Scaffolds using fragment-docking based e-pharmacophore modeling and binary QSAR-based virtual screening protocols pipeline
2018, Journal of Molecular Graphics and ModellingCitation Excerpt :Innate immune cells of RA patients in activated form release a variety of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNFα) and interleukin 1 (IL-1) [7–9], these mediators have a key role in inflammation of joints and destruction of tissues by stimulating the metalloproteinase production [3]. RA patients have higher concentration of these two cytokines in plasma and synovial fluids [10,11]. TNFα is a cytokine present in the form of homotrimer, and its excessive production in the immune system is linked with many chronic inflammatory diseases including RA, Crohn's disease, and psoriasis [12].
Copyright © 1988 Published by Elsevier Ltd.